Patents Assigned to Cenetron Diagnostics LLC
  • Publication number: 20110282043
    Abstract: Embodiments of the invention are directed to compositions and methods that use non-extendable oligonucleotides to enhance or improve synthesis or amplification of nucleic acids.
    Type: Application
    Filed: March 11, 2011
    Publication date: November 17, 2011
    Applicant: Cenetron Diagnostics LLC
    Inventor: Dwight Dubois
  • Patent number: 7033749
    Abstract: The present invention relates to nuclease resistant nucleic acids in general and ribonuclease resistant RNAs in particular. Methods of making and using such nucleic acids are disclosed.
    Type: Grant
    Filed: April 10, 2002
    Date of Patent: April 25, 2006
    Assignees: Ambion, Inc., Cenetron Diagnostics LLC
    Inventors: Brittan L. Pasloske, Dwight B. DuBois, David M. Brown, Matthew M. Winkler
  • Patent number: 5677124
    Abstract: The present invention is directed to the process of creating a recombinant nucleic acid standard which is resistant to ribonuclease digestion and is non-infectious. A single strand of recombinant nucleic acid is encapsidated by bacteriophage proteins. The recombinant nucleic acid is a hybrid sequence encoding bacteriophage proteins and a specific non-bacteriophage sequence. A non-bacteriophage RNA sequence can be used as an RNA standard to help quantify the number of RNA molecules in an unknown sample. The recombinant RNA in its packaged form is highly resistant to ribonucleases, insuring that the RNA standard is not compromised by inadvertent ribonuclease contamination. These "ARMORED RNA" standards are ideal as RNA standards for the quantification of RNA viruses such as HIV and HCV from human body fluids such as blood and cerebrospinal fluid.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: October 14, 1997
    Assignees: Ambion, Inc., Cenetron Diagnostics LLC
    Inventors: Dwight B. DuBois, Matthew M. Winkler, Brittan L. Pasloske